{"id":1036303,"date":"2012-04-07T10:10:48","date_gmt":"2012-04-07T10:10:48","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/the-biotechnology-industry-organization-announces-e-newsletter-redesign.php"},"modified":"2024-08-17T15:55:23","modified_gmt":"2024-08-17T19:55:23","slug":"the-biotechnology-industry-organization-announces-e-newsletter-redesign","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/the-biotechnology-industry-organization-announces-e-newsletter-redesign.php","title":{"rendered":"The Biotechnology Industry Organization Announces e-Newsletter Redesign"},"content":{"rendered":"<p><p>    WASHINGTON--(BUSINESS WIRE)--  <\/p>\n<p>    Following on the redesign of BIO.org, the primary website for    the Biotechnology Industry Organization (BIO), and the relaunch    of BIOtechNOW, a multiblog platform that compiles all of the    organizations blogs, BIO announced the redesign of the primary    e-newsletter, Biotech NOW, which will now be called BIO    Communiqu.  <\/p>\n<p>    Through a survey of our subscribers, we found that people from    all sectors of the biotechnology industry subscribe to    our e-newsletter, BIO President and CEO Jim Greenwood    explained. With that in mind, we knew the demand and desire    for an expanded array of BIO content existed which we hope to    satisfy with this new endeavor.  <\/p>\n<p>    The Communiqu compiles all of the organizations latest    online content in to an electronic publication to be    distributed every two weeks for the biotechnology industry.  <\/p>\n<p>    In addition, the new brand and design encompasses the look and    feel of all BIOs online properties while providing more    critical information about the biotechnology industry, updating    subscribers on BIO activities and events, and providing    industry insights and opinions from BIO staff and industry    experts.  <\/p>\n<p>    The Communiqu is sent to over 100,000 biotechnology    professionals, academics, and scientists. The previous    e-newsletter, BIOtechNOW, was a monthly publication that    promoted content from the organizations multiblog platform of    the same name.  <\/p>\n<p>    To subscribe or learn more about the Communiqu, please    visit     <a href=\"http:\/\/www.bio.org\/enewsletter\" rel=\"nofollow\">http:\/\/www.bio.org\/enewsletter<\/a>. For advertising opportunities    please contact Evan Hart at     <a href=\"mailto:ehart@bio.org\">ehart@bio.org<\/a> or 202-962-9200.  <\/p>\n<p>    Upcoming BIO Events  <\/p>\n<p>        BIO IP Counsels Committee Conference    April 16  18, 2012    Austin, TX  <\/p>\n<p>        World Congress on Industrial Biotechnology &    Bioprocessing    April 29 - May 2, 2012    Orlando, FL  <\/p>\n<\/p>\n<p>Read more:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/biotechnology-industry-organization-announces-e-151800755.html\" title=\"The Biotechnology Industry Organization Announces e-Newsletter Redesign\" rel=\"noopener\">The Biotechnology Industry Organization Announces e-Newsletter Redesign<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> WASHINGTON--(BUSINESS WIRE)-- Following on the redesign of BIO.org, the primary website for the Biotechnology Industry Organization (BIO), and the relaunch of BIOtechNOW, a multiblog platform that compiles all of the organizations blogs, BIO announced the redesign of the primary e-newsletter, Biotech NOW, which will now be called BIO Communiqu. Through a survey of our subscribers, we found that people from all sectors of the biotechnology industry subscribe to our e-newsletter, BIO President and CEO Jim Greenwood explained. With that in mind, we knew the demand and desire for an expanded array of BIO content existed which we hope to satisfy with this new endeavor <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/the-biotechnology-industry-organization-announces-e-newsletter-redesign.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-1036303","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1036303"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1036303"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1036303\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1036303"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1036303"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1036303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}